ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 355461 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 355461; 2) Community: the network communities that were significantly associated with the response to NSC 355461; 3) Molecule: the relationships between components within communities and NSC 355461; 4) MDR: the compounds that were significantly associated with the NSC 355461.

NSC Compound Enrichment Correlation
NSC 744331 (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd 0.0244632509325736 0.2995469
NSC 130785 Null 0.0244718705444135 0.27596607
NSC 23936 Null 0.0244718705444135 0.44974495
NSC 266047 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) 0.0244718705444135 0.37305315
NSC 30863 Null 0.0244718705444135 0.3400035
NSC 31768 Null 0.0244718705444135 0.072751921
NSC 349447 Indolo[2,1-b]quinazoline-6,12-dione (8CI9CI) 0.0244718705444135 0.24044795
NSC 656238 2-Methyl-4,8-dihydrobenzo[1,2-b:5,4-b']dithiophene-4,8-dione 0.0244718705444135 0.10218969
NSC 373355 Saframycin R 0.0244718705444139 0.17139815
NSC 381811 Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- 0.0244718705444139 0.16317839
Total:57  Current:28    [First] [Prev] [Next] [Last]